-
My Account
co-presented by
ASSOCIATE SPONSORS
In App
My Account
co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Feb 02, 12:51Prev. Close
640.00
Open Price
640.00
Bid Price (Qty.)
645.10 (100)
Offer Price (Qty.)
665.00 (100)
| Key Financial Ratios of Remus Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 65.21 | 152.01 | |
| Diluted EPS (Rs.) | 65.21 | 152.01 | |
| Cash EPS (Rs.) | 68.40 | 182.44 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 434.40 | 589.66 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 434.40 | 589.66 | |
| Revenue from Operations/Share (Rs.) | 1,053.24 | 1,442.63 | |
| PBDIT/Share (Rs.) | 86.03 | 225.45 | |
| PBIT/Share (Rs.) | 82.85 | 219.37 | |
| PBT/Share (Rs.) | 80.37 | 216.08 | |
| Net Profit/Share (Rs.) | 65.23 | 176.36 | |
| NP After MI And SOA / Share (Rs.) | 49.35 | 176.36 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 8.16 | 15.62 | |
| PBIT Margin (%) | 7.86 | 15.20 | |
| PBT Margin (%) | 7.63 | 14.97 | |
| Net Profit Margin (%) | 6.19 | 12.22 | |
| NP After MI And SOA Margin (%) | 4.68 | 12.22 | |
| Return on Networth/Equity (%) | 11.36 | 29.90 | |
| Return on Capital Employed (%) | 15.68 | 29.97 | |
| Return on Assets (%) | 6.71 | 10.09 | |
| Total Debt/Equity (X) | 0.08 | 0.13 | |
| Asset Turnover Ratio (%) | 1.80 | 0.00 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 1.82 | 1.40 | |
| Quick Ratio (X) | 1.40 | 1.12 | |
| Inventory Turnover Ratio (X) | 13.14 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 4.05 | 2.26 | |
| Dividend Payout Ratio (CP) (%) | 3.81 | 2.19 | |
| Earnings Retention Ratio (%) | 95.95 | 97.74 | |
| Cash Earnings Retention Ratio (%) | 96.19 | 97.81 | |
| Coverage Ratios | |||
| Interest Coverage Ratios (%) | 34.71 | 68.56 | |
| Interest Coverage Ratios (Post Tax) (%) | 34.71 | 68.56 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 1,358.10 | 1,018.43 | |
| EV/Net Operating Revenue (X) | 2.19 | 4.79 | |
| EV/EBITDA (X) | 26.80 | 30.67 | |
| MarketCap/Net Operating Revenue (X) | 2.13 | 4.78 | |
| Retention Ratios (%) | 95.94 | 97.73 | |
| Price/BV (X) | 5.15 | 11.70 | |
| Price/Net Operating Revenue | 2.13 | 4.78 | |
| Earnings Yield | 0.02 | 0.03 |
